TrialJournal of inherited metabolic disease2026

Phase 3 Randomized Trial Results of DTX401 AAV Gene Therapy for the Treatment of GSDIa.

John J Mitchell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.